Form D · Biotechnology
Dermata Therapeutics, Inc.
San Diego, CA · CIK 0001853816
Offering snapshot reported Jan 7, 2026 · SEC filing
- Reported sold
- $4.12M Offering amount: $4.12M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2026 | Initial | $4,124,591 | No comparison | 14 | SEC filing |
| Feb 4, 2025 | Amendment | $2,550,000 | $0vs Jan 28, 2025 | 8 | SEC filing |
| Jan 28, 2025 | Initial | $2,550,000 | No comparison | 7 | SEC filing |
| Sep 27, 2024 | Initial | $3,498,089 | No comparison | 1 | SEC filing |
| Jun 12, 2023 | Initial | $0 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $343K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-569228
Includes a cash fee of 7% of gross proceeds from outside investors and 3.5% from inside investors, 1% management fee, $25,000 non-accountable expense allowance, and $40,000 accountable expense allowance.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 000000375 |
Source: Form D, filed Jan 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maria Bedoya Toro Munera | Executive |
| Brittany Bradrick | Director |
| Mary Fisher | Director |
| David Hale | Director |
| Steven J. Mento | Director |
| Christopher J. Nardo | Executive |
| Gerald Proehl | Director, Executive |
| Andrew Sandler | Director |
| Kathleen Scott | Director |
| Kyri K. Van Hoose | Executive |
| Wendell Wierenga | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3525 Del Mar Heights Rd. #322
San Diego, CA, 92130
San Diego, CA, 92130